<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">clinvest</journal-id><journal-title-group><journal-title xml:lang="ru">Качественная клиническая практика</journal-title><trans-title-group xml:lang="en"><trans-title>Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2588-0519</issn><issn pub-type="epub">2618-8473</issn><publisher><publisher-name>ООО «Издательство ОКИ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2588-0519-2024-2-33-42</article-id><article-id custom-type="edn" pub-id-type="custom">LYNKOF</article-id><article-id custom-type="elpub" pub-id-type="custom">clinvest-715</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL PHARMACOLOGY</subject></subj-group></article-categories><title-group><article-title>Тренды в клинической фармакологии согласно публикациям в международных и российских специализированных журналах</article-title><trans-title-group xml:lang="en"><trans-title>Trends in clinical pharmacology as represented by international and specialized journals</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1919-2909</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колбин</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolbin</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колбин Алексей Сергеевич - д. м. н., профессор, зав. кафедрой клинической фармакологии и доказательной медицины</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Aleksey S. Kolbin - Dr. Sci. (Med.), Professor, Head of the Department of Clinical Pharmacology and Evidence Based Medicine</p><p>Saint-Petersburg</p></bio><email xlink:type="simple">kolbin1971@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2121-094X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Радаева</surname><given-names>К. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Radaeva</surname><given-names>K. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Радаева Ксения Сергеевна - ординатор кафедры клинической фармакологии и доказательной медицины</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Kseniia S. Radaeva - Resident of the Department of Clinical Pharmacology and Evidence Based Medicine</p><p>Saint-Petersburg</p></bio><email xlink:type="simple">xenrada@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2863-792X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мотринчук</surname><given-names>А. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Motrinchuk</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мотринчук Айтэн Шерифовна - ординатор кафедры клинической фармакологии и доказательной медицины</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Aiten S. Motrinchuk - Resident of the Department of Clinical Pharmacology and Evidence Based Medicine</p><p>Saint-Petersburg</p></bio><email xlink:type="simple">aitesha555@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-6681-232X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Свечкарева</surname><given-names>И. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Svechkareva</surname><given-names>I. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Свечкарева Изабелла Размиковна - ординатор кафедры клинической фармакологии и доказательной медицины</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Izabella R. Svechkareva — Resident of the Department of Clinical Pharmacology and Evidence Based Medicine</p><p>Saint-Petersburg</p></bio><email xlink:type="simple">Bellaliza@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pavlov First Saint Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>25</day><month>06</month><year>2024</year></pub-date><volume>0</volume><issue>2</issue><fpage>33</fpage><lpage>42</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Колбин А.С., Радаева К.С., Мотринчук А.Ш., Свечкарева И.Р., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Колбин А.С., Радаева К.С., Мотринчук А.Ш., Свечкарева И.Р.</copyright-holder><copyright-holder xml:lang="en">Kolbin A.S., Radaeva K.S., Motrinchuk A.S., Svechkareva I.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.clinvest.ru/jour/article/view/715">https://www.clinvest.ru/jour/article/view/715</self-uri><abstract><p>Актуальность. Клиническая фармакология — быстро развивающаяся область медицины. С появлением современных технологий, клиническая фармакология продолжает эволюционировать, что отражается в публикациях в специализированных медицинских журналах.Цель работы. Определить, как новые тенденции в клинической фармакологии отразились в публикациях ведущих журналов по клинической фармакологии в России в период с 2015 по 2021 гг., провести сравнительный анализ тенденций с международными журналами с 2015 по 2021 гг.Материалы и методы. Оригинальные статьи, опубликованные в российских журналах-лидерах, были проанализированы и распределены по соответствующим ключевым областям интересов, лекарственным модальностям и терапевтическим областям на основании содержания публикаций тремя авторами независимо. Публикации, мнение по которым у авторов расходились, были обсуждены до достижения консенсуса с использованием модифицированной методики Дельфи. Затем был проведён сравнительный анализ с результатами аналогичного анализа, опубликованного в журнале Clinical pharmacology and Therapeutics.Результаты. В российских журналах большинство публикаций фокусировалось на данных реальной клинической практики. Наиболее часто освещаемыми темами публикаций в международных журналах были фармакометрия / машинное обучение и фармакогенетика. На третьем месте были данные реальной клинической практики. Ведущими терапевтическими областями, представленными в публикациях как в отечественных, так и в международных журналах, были кардиология, онкология и инфекционные заболевания. В подавляющем числе публикаций исследовали различные аспекты применения малых молекул.Выводы. С появлением новых тенденций клиническая фармакология претерпевает изменения, отражаемые в научных статьях, публикуемых в специализированных журналах. Основные направления, отмеченные в отечественных изданиях, соответствуют международным тенденциям.</p></abstract><trans-abstract xml:lang="en"><p>Relevance. Clinical pharmacology is a rapidly evolving field of medicine. The advent of modern technologies has led. The continued evolution of clinical pharmacology, as reflected in publications in specialized medical journals.The aim of this study was to determine how new trends in clinical pharmacology were reflected in the publications of the leading clinical pharmacology journals in Russia during the period from 2015-2021, to conduct a comparative analysis of trends with international journals from 2015-2021.Materials and methods. Original articles published in leading Russian journals were analyzed and categorized into relevant key areas of interest, drug modalities, and therapeutic areas based on the content of the publications independently by three authors. Publications in which authors expressed divergent opinions were discussed until consensus was reached using a modified Delphi method. A comparative analysis was then performed with the results of a similar analysis published in journal “Clinical Pharmacology and Therapeutics”.Results. Most Russian journals and publications have focused on real-world data. The topics most frequently covered in international journals were pharmacometrics, machine learning, and pharmacogenetics. In third place were real-world data. The leading therapeutic areas represented in publications in both Russian and international journals were cardiology, oncology, and infectious diseases. Most publications have focused on various aspects of small molecule use.Conclusions. The novel trends in clinical pharmacology are reflected in the scientific articles published in specialized journals. The principal trends observed in Russian publications are consistent with international tendencies.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>тренды</kwd><kwd>клиническая фармакология</kwd><kwd>научные публикации</kwd><kwd>анализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>trends</kwd><kwd>clinical pharmacology</kwd><kwd>publications</kwd><kwd>analysis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell Bruce J. Materia Medica and Therapeutics: An Introduction to the Rational Treatment of Disease. Maven Books; 2019.</mixed-citation><mixed-citation xml:lang="en">Mitchell Bruce J. Materia Medica and Therapeutics: An Introduction to the Rational Treatment of Disease. Maven Books; 2019.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Колбин А.С. Клиническая фармакология для педиатров: учебное пособие. — Москва: ГЭОТАР-Медиа, 2020. — doi: 10.33029/97045920-1-CPH-2021-1-288</mixed-citation><mixed-citation xml:lang="en">Kolbin A.S. Klinicheskaya farmakologiya dlya pediatrov: uchebnoe posobie. — Moskva: GEOTAR-Media, 2020. (in Russ.) doi: 10.33029/97045920-1-CPH-2021-1-288.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Dollery CT. Clinical pharmacology — the first 75 years and a view of the future. Br J Clin Pharmacol. 2006;61(6):650-665. doi:10.1111/j.1365-2125.2006.02672.x.</mixed-citation><mixed-citation xml:lang="en">Dollery CT. Clinical pharmacology — the first 75 years and a view of the future. Br J Clin Pharmacol. 2006;61(6):650-665. doi:10.1111/j.1365-2125.2006.02672.x.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Сlinical Pharmacology. Scope, Organisation training. Report of a WHO study group. World Health Organ. Tech.Rep.Ser 1970;446:5 – 21.</mixed-citation><mixed-citation xml:lang="en">Сlinical Pharmacology. Scope, Organisation training. Report of a WHO study group. World Health Organ. Tech.Rep.Ser 1970;446:5 – 21.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical Pharmacology. The European challenge. WHO regional Publications, European series 1991; No 39.</mixed-citation><mixed-citation xml:lang="en">Clinical Pharmacology. The European challenge. WHO regional Publications, European series 1991; No 39.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Minichmayr IK, Smith DM, Giacomini KM, van der Graaf PH. Trends in Clinical Pharmacology and Therapeutics. Clin Pharmacol Ther. 2023;114(1):11-14. doi:10.1002/cpt.2931.</mixed-citation><mixed-citation xml:lang="en">Minichmayr IK, Smith DM, Giacomini KM, van der Graaf PH. Trends in Clinical Pharmacology and Therapeutics. Clin Pharmacol Ther. 2023;114(1):11-14. doi:10.1002/cpt.2931.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Решение Совета ЕЭК от 17.03.2022 № 36 "О внесении изменений в Правила регистрации и экспертизы лекарственных средств для медицинского применения"</mixed-citation><mixed-citation xml:lang="en">Reshenie Soveta EEK ot 17.03.2022 № 36 "O vnesenii izmenenii v Pravila registratsii i ekspertizy lekarstvennykh sredstv dlya meditsinskogo primeneniya" (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Клинико-экономический анализ (оценка, выбор медицинских технологий и управление качеством медицинской помощи) / М.А. Авксентьев, В.Б. Герасимов, М.В.Сура; под ред. П.А. Воробьева. — М.: Ньюдиамед, 2004.</mixed-citation><mixed-citation xml:lang="en">Kliniko-ekonomicheskii analiz (otsenka, vybor meditsinskikh tekhnologii i upravlenie kachestvom meditsinskoi pomoshchi). M.A. Avksent'ev, V.B. Gerasimov, M.V.Sura; pod red. P.A. Vorob'eva. — Moscow: N'yudiamed, 2004. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Фармакоэпидемиология: пособие / Т.Л. Галанкин, Е.В. Вербицкая; под ред. А.С. Колбина. – СПб.: Издательство СПбГМУ, 2015.</mixed-citation><mixed-citation xml:lang="en">Farmakoepidemiologiya: posobie. T.L. Galankin, E.V. Verbitskaya; pod red. A.S. Kolbina. – Saint – Petersburg: Izdatel'stvo SPbGMU, 2015 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">PharmGKB® https://www.pharmgkb.org/ (2001—2019).</mixed-citation><mixed-citation xml:lang="en">PharmGKB® https://www.pharmgkb.org/ (2001—2019).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Сычев Д.А., Отделенов В.А. Межлекарственные взаимодействия в практике интерниста: взгляд клинического фармаколога. Справочник поликлинического врача. 2014; 12:18-21.</mixed-citation><mixed-citation xml:lang="en">Sychev D.A., Otdelenov V.A. Mezhlekarstvennye vzaimodeistviya v praktike internista: vzglyad klinicheskogo farmakologa. Spravochnik poliklinicheskogo vracha. 2014; 12:18-21. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Giacomini KM, Huang SM. More Than Pharmacokinetics: Transporters in Clinical Pharmacology. Clin Pharmacol Ther. 2022;112(3):423-426. doi:10.1002/cpt.2710</mixed-citation><mixed-citation xml:lang="en">Giacomini KM, Huang SM. More Than Pharmacokinetics: Transporters in Clinical Pharmacology. Clin Pharmacol Ther. 2022;112(3):423-426. doi:10.1002/cpt.2710</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Barrett JS, Bishai R, Bucci-Rechtweg C, et al. Challenges and Opportunities in the Development of Medical Therapies for Pediatric Populations and the Role of Extrapolation. Clin Pharmacol Ther. 2018;103(3):419-433. doi:10.1002/cpt.1000</mixed-citation><mixed-citation xml:lang="en">Barrett JS, Bishai R, Bucci-Rechtweg C, et al. Challenges and Opportunities in the Development of Medical Therapies for Pediatric Populations and the Role of Extrapolation. Clin Pharmacol Ther. 2018;103(3):419-433. doi:10.1002/cpt.1000</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Andaur Navarro CL, Damen JAA, Takada T, et al. Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review. BMJ. 2021;375: n2281. doi:10.1136/bmj. n2281.</mixed-citation><mixed-citation xml:lang="en">Andaur Navarro CL, Damen JAA, Takada T, et al. Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review. BMJ. 2021;375: n2281. doi:10.1136/bmj. n2281.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Fraterman S, Xie W, Wu C, Thielmann M, Yudhistiara B. New drug modalities offer promise and Peril. 2023. Доступно на: https://www.bcg.com/publications/2023/benefits-and-risks-of-new-drug-modalities. Дата обращения: 01.01.2024.</mixed-citation><mixed-citation xml:lang="en">Fraterman S, Xie W, Wu C, Thielmann M, Yudhistiara B. New drug modalities offer promise and Peril. 2023. Доступно на: https://www.bcg.com/publications/2023/benefits-and-risks-of-new-drug-modalities. Дата обращения: 01.01.2024.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Гомон Ю.М., Колбин А.С. Лекарственные препараты передовой терапии: перспективы внедрения в клиническую практику в педиатрии. Вопросы современной педиатрии. 2024;23(1):34–47.</mixed-citation><mixed-citation xml:lang="en">Gomon Yu.M., Kolbin A.S. Lekarstvennye preparaty peredovoi terapii: perspektivy vnedreniya v klinicheskuyu praktiku v pediatrii. Voprosy sovremennoi pediatrii. 2024;23(1):34–47. (In Russ.) doi: 10.15690/vsp.v23i1.2654.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y, Zhu H, Madabushi R, Liu Q, Huang SM, Zineh I. Model-Informed Drug Development: Current US Regulatory Practice and Future Considerations. Clin Pharmacol Ther. 2019;105(4):899-911. doi:10.1002/cpt.1363.</mixed-citation><mixed-citation xml:lang="en">Wang Y, Zhu H, Madabushi R, Liu Q, Huang SM, Zineh I. Model-Informed Drug Development: Current US Regulatory Practice and Future Considerations. Clin Pharmacol Ther. 2019;105(4):899-911. doi:10.1002/cpt.1363.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Madabushi R, Wang Y, Zineh I. A Holistic and Integrative Approach for Advancing Model-Informed Drug Development. CPT Pharmacometrics Syst Pharmacol. 2019;8(1):9-11. doi:10.1002/psp4.12379.</mixed-citation><mixed-citation xml:lang="en">Madabushi R, Wang Y, Zineh I. A Holistic and Integrative Approach for Advancing Model-Informed Drug Development. CPT Pharmacometrics Syst Pharmacol. 2019;8(1):9-11. doi:10.1002/psp4.12379.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Колбин А.С., Радаева К.С. Дозирование лекарственных средств в педиатрии: возможные подходы. Вопросы современной педиатрии. 2023; 22(4):289-297. doi: 10.15690/vsp.v22i4.2593</mixed-citation><mixed-citation xml:lang="en">Kolbin Alexey S., Radaeva Kseniya S. Drug Dosing in Pediatrics: Possible Approaches. Voprosy sovremennoi pediatrii. 2023;22(4):289–297. (In Russ). doi: https://doi.org/10.15690/vsp.v22i4.2593.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Parra-Guillen ZP, Sancho-Araiz A, Mayawala K, et al. Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically-Based Modeling. Clin Pharmacol Ther. 2023;114(3):623-632. doi:10.1002/cpt.2937.</mixed-citation><mixed-citation xml:lang="en">Parra-Guillen ZP, Sancho-Araiz A, Mayawala K, et al. Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically-Based Modeling. Clin Pharmacol Ther. 2023;114(3):623-632. doi:10.1002/cpt.2937.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Renardy M, Prokopienko AJ, Maxwell JR, et al. A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development. Clin Pharmacol Ther. 2023;114(3):633-643. doi:10.1002/cpt.2952.</mixed-citation><mixed-citation xml:lang="en">Renardy M, Prokopienko AJ, Maxwell JR, et al. A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development. Clin Pharmacol Ther. 2023;114(3):633-643. doi:10.1002/cpt.2952.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Choi Y, Vinks A, van der Graaf PH. Novel Therapeutic Modalities: The Future is Now. Clin Pharmacol Ther. 2023;114(3):493-496. doi: 10.1002/cpt.2996.</mixed-citation><mixed-citation xml:lang="en">Choi Y, Vinks A, van der Graaf PH. Novel Therapeutic Modalities: The Future is Now. Clin Pharmacol Ther. 2023;114(3):493-496. doi: 10.1002/cpt.2996.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Weinshilboum RM, Wang L. Pharmacogenomics: Precision Medicine and Drug Response. Mayo Clin Proc. 2017;92(11):1711-1722. doi: 10.1016/j.mayocp.2017.09.001.</mixed-citation><mixed-citation xml:lang="en">Weinshilboum RM, Wang L. Pharmacogenomics: Precision Medicine and Drug Response. Mayo Clin Proc. 2017;92(11):1711-1722. doi: 10.1016/j.mayocp.2017.09.001.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hattinger CM, Patrizio MP, Luppi S, Serra M. Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact. Int J Mol Sci. 2020;21(13):4659. doi:10.3390/ijms21134659.</mixed-citation><mixed-citation xml:lang="en">Hattinger CM, Patrizio MP, Luppi S, Serra M. Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact. Int J Mol Sci. 2020;21(13):4659. doi:10.3390/ijms21134659.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Jeibouei S, Akbari ME, Kalbasi A, et al. Personalized medicine in breast cancer: pharmacogenomics approaches. Pharmgenomics Pers Med. 2019; 12:59-73. doi:10.2147/PGPM.S167886.</mixed-citation><mixed-citation xml:lang="en">Jeibouei S, Akbari ME, Kalbasi A, et al. Personalized medicine in breast cancer: pharmacogenomics approaches. Pharmgenomics Pers Med. 2019; 12:59-73. doi:10.2147/PGPM.S167886.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou DT et al. Emerging role for pharmacogenomics in HIV research in Africa. Future Virology. 2021;16(5):307-310. doi:10.2217/fvl-2020-0388.</mixed-citation><mixed-citation xml:lang="en">Zhou DT et al. Emerging role for pharmacogenomics in HIV research in Africa. Future Virology. 2021;16(5):307-310. doi:10.2217/fvl-2020-0388.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Verstegen RHJ, Ito S. The Future of Precision Medicine. Clin Pharmacol Ther. 2019;106(5):903-906. doi:10.1002/cpt.1622.</mixed-citation><mixed-citation xml:lang="en">Verstegen RHJ, Ito S. The Future of Precision Medicine. Clin Pharmacol Ther. 2019;106(5):903-906. doi:10.1002/cpt.1622.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Mitra A, Ahmed MA, Krishna R, et al. Model-Informed Approaches and Innovative Clinical Trial Design for Adeno-Associated Viral Vector-Based Gene Therapy Product Development: A White Paper. Clin Pharmacol Ther. 2023;114(3):515-529. doi:10.1002/cpt.2972.</mixed-citation><mixed-citation xml:lang="en">Mitra A, Ahmed MA, Krishna R, et al. Model-Informed Approaches and Innovative Clinical Trial Design for Adeno-Associated Viral Vector-Based Gene Therapy Product Development: A White Paper. Clin Pharmacol Ther. 2023;114(3):515-529. doi:10.1002/cpt.2972.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Q, Ramamoorthy A, Huang SM. Real-World Data and Clinical Pharmacology: A Regulatory Science Perspective. Clin Pharmacol Ther. 2019;106(1):67-71. doi:10.1002/cpt.1413.</mixed-citation><mixed-citation xml:lang="en">Liu Q, Ramamoorthy A, Huang SM. Real-World Data and Clinical Pharmacology: A Regulatory Science Perspective. Clin Pharmacol Ther. 2019;106(1):67-71. doi:10.1002/cpt.1413.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Колбин А.С., Ниязов Р.Р., Калиниченко В.В., Глаголев С.В. Применение данных реальной клинической практики с позиции клинической фармакологии при разработке лекарственных средств. Клиническая фармакология и терапия. 2023;32(4):16-23.</mixed-citation><mixed-citation xml:lang="en">Kolbin AS, Niyazov RR, Kalinichenko VV, Glagolev SV. Use of realworld data for drug development. Klinicheskaya farmakologiya i terapiya = Clin Pharmacol Ther. 2023;32(4):16-23 (In Russ.) doi: 10.32756/0869-5490-2023-4-16-23.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Колбин А.С. Зачем нужен новый научный электронный журнал «Реальная клиническая практика: данные и доказательства»? Реальная клиническая практика: данные и доказательства. 2021;1(1):2-4.</mixed-citation><mixed-citation xml:lang="en">Kolbin A.S. Why do we need "Real-World Data &amp; Evidence", the new scientific electronic journal? Real-World Data &amp; Evidence. 2021;1(1):2-4. (In Russ.) doi: 10.37489/2782-3784-myrwd-1.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Распоряжение Правительства Российской Федерации "Стратегия развития фармацевтической промышленности Российской Федерации на период до 2030 года" от 07.04.2023 № 1495-р. Официальный интернет-портал правовой информации, 2023</mixed-citation><mixed-citation xml:lang="en">Rasporyazhenie Pravitel'stva Rossiiskoi Federatsii "Strategiya razvitiya farmatsevticheskoi promyshlennosti Rossiiskoi Federatsii na period do 2030 goda" ot 07.04.2023 № 1495-r. Ofitsial'nyi internet-portal pravovoi informatsii, 2023. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Harding SD, Armstrong JF, Faccenda E, et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2024. Nucleic Acids Res. 2024;52(D1): D1438-D1449. doi:10.1093/nar/gkad944. 34. CIOMS Cumulative glossary with a focus on pharmacovigilance. Geneva, Switzerland: Council for International Organizations of Medical Sciences (CIOMS), 2022. doi: 10.56759/ocef1297.</mixed-citation><mixed-citation xml:lang="en">Harding SD, Armstrong JF, Faccenda E, et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2024. Nucleic Acids Res. 2024;52(D1): D1438-D1449. doi:10.1093/nar/gkad944. 34. CIOMS Cumulative glossary with a focus on pharmacovigilance. Geneva, Switzerland: Council for International Organizations of Medical Sciences (CIOMS), 2022. doi: 10.56759/ocef1297.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
